ReviewFrontiers in immunology2024
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy.
Leona Raskova Kafkova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled itcites it